OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for $2 billion
Ontario Institute for Cancer Research News
by hcostie
1d ago
This landmark acquisition of the Hamilton-based company comes after years of funding and support from OICR and FACIT. AstraZeneca’s $2 billion (USD) acquisition of Hamilton-based Fusion Pharmaceuticals marks a major milestone for precision medicine in cancer and for Ontario’s life sciences sector, and the Ontario Institute for Cancer Research (OICR) is proud to have helped launch this made-in-Ontario success story. Dr. John Valliant Fusion is a clinical-stage oncology company developing and manufacturing radiopharmaceuticals, a new class of cancer therapy that uses radioactive isotopes linked ..read more
Visit website
How the Ontario Cancer Research Ethics Board protects participants while streamlining research in the province
Ontario Institute for Cancer Research News
by hcostie
6d ago
A program of OICR, the Ontario Cancer Research Ethics Board (OCREB) includes more than 40 expert reviewers who specialize in cancer clinical trials. Ethics boards are an essential part of cancer research. They work to protect the rights and welfare of research participants who volunteer to join studies that generate knowledge and innovations that may help people live longer, better lives. Most hospitals that do clinical research have their own research ethics boards that review study protocols, participant consent forms and other study documents. But cancer research keeps changing and evolvin ..read more
Visit website
Ask a cancer researcher: Is there a blood test for cancer?
Ontario Institute for Cancer Research News
by hcostie
6d ago
Ontario Health Study participant Brenda Czich asks OICR’s Director of Genomics Dr. Trevor Pugh about blood tests for cancer. Watch the video to learn about cancer blood tests that are currently available, new ones under development and how these types of tests can help those at risk of hereditary cancers. The post Ask a cancer researcher: Is there a blood test for cancer? appeared first on Ontario Institute for Cancer Research ..read more
Visit website
How AI can help diagnose cancers that are otherwise hard to spot
Ontario Institute for Cancer Research News
by hcostie
3w ago
OICR-supported researchers are harnessing the power of artificial intelligence to help diagnose cancer quickly and accurately. The difference between cancerous and non-cancerous tissue can be so subtle it’s almost imperceptible. And yet distinguishing one from the other can mean the difference between life and death. Early detection is critical to treating cancer effectively, and it’s one of the pillars of OICR’s research strategy. As part of that strategy, the institute is supporting a range of cutting-edge studies that aim to make detecting and diagnosing cancer easier for clinicians by har ..read more
Visit website
“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers
Ontario Institute for Cancer Research News
by hcostie
1M ago
OICR’s Translational Research Initiatives (TRIs) made a lasting impact for patients. In 2017, ovarian cancer research was due for a new approach. Despite the best efforts of scientists, clinicians and patients, outcomes hadn’t improved for almost 50 years, and the disease always seemed one step ahead. Gaining ground on ovarian cancer was going take something bold. It was going to take teams of experts asking questions that matter to cancer patients and working together to answer them. And that’s exactly what OICR had in mind when it created the Ovarian Cancer Translational Research Initiative ..read more
Visit website
Using AI to connect cancer patients with cutting-edge clinical trials
Ontario Institute for Cancer Research News
by hcostie
1M ago
A team of Ontario researchers is developing PMATCH, an automated system to match precision medicine clinical trials with eligible cancer patients. Clinical trials can be the best way to test new cancer technologies and treatments, and can give patients access to potentially life-saving innovations. Yet connecting patients with a trial they’re eligible for can be like finding a needle in a haystack. Clinicians and researchers are tasked with identifying all available trial options and their unique eligibility criteria, and comparing that against patients’ health history and complex medical inf ..read more
Visit website
New PFAC Chair takes lead of growing, evolving community of OICR patient partners
Ontario Institute for Cancer Research News
by hcostie
1M ago
Blood cancer survivor Terry Hawrysh is the new Chair of OICR’s Patient and Family Advisory Council (PFAC). Though Terry Hawrysh has seen major strides in patient partnership since he first got involved in cancer research, he thinks we’re just scratching the surface of what patient partners can achieve. So he’s excited to help lead the next evolution of patient partnership in cancer research as the new Chair of OICR’s Patient and Family Advisory Council (PFAC). “As Chair, I have a wonderful opportunity to draw on the collective knowledge and experience of many diverse and dynamic patients partn ..read more
Visit website
Ask a cancer researcher: How can Ontarians get tested for hereditary cancers?
Ontario Institute for Cancer Research News
by hcostie
1M ago
Medical Geneticist Dr. Raymond Kim answers a question about what genetic testing is available in Ontario. Having close family members with cancer could mean you have a higher risk of developing certain cancers. And so people with a family history of cancer may want to get genetic testing to better understand their risks. In our latest Ask a Cancer Researcher video, University Health Network Medical Geneticist Dr. Raymond Kim answers a question from Coburg resident Jo Ann Kropf-Hedley about what genetic testing is available in Ontario. Kim also explains how the Ontario Hereditary Can ..read more
Visit website
AI helps find new leads for brain cancer drug discovery
Ontario Institute for Cancer Research News
by hcostie
2M ago
Research led by OICR and SickKids used machine learning to find links between cancer outcomes and druggable proteins. Ontario scientists used advanced computing techniques to generate a catalogue of potential targets for future drug discovery research, as well as two promising targets for brain cancer drugs. In a study published in the EMBO Journal, researchers used machine learning — a type of artificial intelligence (AI) that can learn from data and make predictions — to analyze the gene expression of more than 9,000 tumour samples across 33 cancer types. They looked specifically at a group ..read more
Visit website
Ask a cancer researcher: What are ‘imaging probes’ and how can they help diagnose prostate cancer?
Ontario Institute for Cancer Research News
by hcostie
2M ago
PhD student Pamela Penawou answers a question from a prostate cancer survivor. One of the most exciting new innovations in diagnosing cancer is the development of ‘imaging probes’ that attach themselves to cancer cells to show the precise location of a tumour. In our latest Ask a Cancer Researcher video, prostate cancer survivor and retired medical physicist Jerry Battista asks about how these probes work, and how they can be harnessed to improve the way prostate cancer is diagnosed and treated. His question is answered by McMaster PhD student and radiochemistry researcher Pamela Penawou. See ..read more
Visit website

Follow Ontario Institute for Cancer Research News on FeedSpot

Continue with Google
Continue with Apple
OR